CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pulmo BioTech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pulmo BioTech Inc
Suite 7B, 1035 Park Avenue
Phone: (646) 827-9362p:646 827-9362 NEW YORK, NY  10028-0912  United States Ticker: PLMO PLMO

On 5/5/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Pulmo BioTech Inc for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.

Business Summary
Pulmo BioTech Inc. specializes in the development and marketing of medical technology and research. PulmoScience Inc. is the Company’s subsidiary. As of July 6, 2010, PulmoScience Inc. developed a non-invasive Molecular Imaging technique for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the name, PulmoBind. PulmoBind uses an intravenously delivered radionuclide tagged molecule, which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician.
(Source: PRESS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20093/31/2009YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Treasurer, Director GarryMcCann 53 5/1/2008 3/1/2008
Chief Financial Officer Rajiv K.Garg 54 5/1/2008 5/1/2008
Secretary Peter B.Hirshfield 67 3/1/2008 3/1/2008

Business Names
Business Name
ACAQ
Acorn Acquisition Corp.
PLMO
Pulmo BioTech, Inc.
PulmoScience Inc
Syntony Group, Inc.

General Information
Outstanding Shares: 52,621,574 (As of 12/31/2009)
Shareholders: 3,534
Stock Exchange: OTC
Federal Tax Id: 205622985
Fax Number: (646) 349-1665


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023